| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |